Prostate SABR With Intra-Prostatic SABR Boost
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Addition of Opaganib to Androgen Antagonists in Patients With mCRPC
- Status
- COMPLETED
- Phase
- PHASE2
Use of Pedometer Following Radical Prostatectomy
- Status
- UNKNOWN
- Phase
- NA
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
- Status
- RECRUITING
- Phase
- N/A
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety Assessment of IRE of Localized Prostate Cancer
- Status
- UNKNOWN
- Phase
- NA
Deep Learning for Prostate Segmentation
- Status
- UNKNOWN
- Phase
- N/A
Serial MRI Scans During Radiation Therapy
- Status
- RECRUITING
- Phase
- NA
Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence
- Status
- COMPLETED
- Phase
- PHASE3
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Recommended Dose Estimation of BP-C2
- Status
- RECRUITING
- Phase
- PHASE1
Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection
- Status
- COMPLETED
- Phase
- NA
Cardiovascular Events in GnRH Agonist vs. Antagonist
- Status
- UNKNOWN
- Phase
- PHASE2
Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate.
- Status
- UNKNOWN
- Phase
- NA
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
- Status
- UNKNOWN
- Phase
- NA
PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study
- Status
- TERMINATED
- Phase
- PHASE2
Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2